An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer
Public ClinicalTrials.gov record NCT02743494. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects With Resected Esophageal, or Gastroesophageal Junction Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to determine whether Nivolumab will improve disease-free survival compared with placebo.
Study identification
- NCT ID
- NCT02743494
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 794 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 14, 2016 (Actual)
- Primary completion
- May 12, 2020 (Actual)
- Completion
- Nov 7, 2024 (Actual)
- Last update posted
- Nov 18, 2025
2016 – 2024
United States locations
- U.S. sites
- 38
- U.S. states
- 19
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Local Institution - 0250 | Tucson | Arizona | 85711 | — |
| Local Institution - 0026 | Los Angeles | California | 90033 | — |
| Local Institution - 0023 | San Francisco | California | 94115 | — |
| Local Institution - 0068 | San Francisco | California | 94158 | — |
| Local Institution - 0151 | Aurora | Colorado | 80045 | — |
| Local Institution - 0247 | Denver | Colorado | 80218 | — |
| Local Institution - 0054 | Washington D.C. | District of Columbia | 20007 | — |
| Local Institution - 0113 | Fort Myers | Florida | 33901 | — |
| Local Institution - 0131 | Jacksonville | Florida | 32256 | — |
| Local Institution - 0226 | Miami | Florida | 33136 | — |
| Local Institution - 0022 | Pensacola | Florida | 32504 | — |
| Local Institution - 0114 | St. Petersburg | Florida | 33705 | — |
| Local Institution - 0153 | Chicago | Illinois | 60637 | — |
| Local Institution - 0025 | Baltimore | Maryland | 21202 | — |
| Local Institution - 0055 | Boston | Massachusetts | 02215 | — |
| Local Institution - 0170 | Boston | Massachusetts | 02215 | — |
| Local Institution - 0171 | Boston | Massachusetts | 02215 | — |
| Local Institution - 0217 | Boston | Massachusetts | 02215 | — |
| Local Institution - 0027 | St Louis | Missouri | 63110 | — |
| Local Institution - 0058 | Hackensack | New Jersey | 07601 | — |
| Local Institution - 0066 | Neptune City | New Jersey | 07753 | — |
| Local Institution - 0032 | New York | New York | 10016 | — |
| Local Institution - 0205 | The Bronx | New York | 10461 | — |
| Local Institution - 0033 | Charlotte | North Carolina | 28262 | — |
| Local Institution - 0024 | Durham | North Carolina | 27710 | — |
| Local Institution - 0056 | Cleveland | Ohio | 44106 | — |
| Local Institution - 0165 | Portland | Oregon | 97239 | — |
| Local Institution - 0101 | Allentown | Pennsylvania | 18103 | — |
| Local Institution - 0048 | Philadelphia | Pennsylvania | 19111 | — |
| Local Institution - 0116 | Pittsburgh | Pennsylvania | 15212 | — |
| Local Institution - 0111 | Nashville | Tennessee | 37203 | — |
| Local Institution - 0130 | Nashville | Tennessee | 37232 | — |
| Local Institution - 0216 | Dallas | Texas | 75216 | — |
| Local Institution - 0248 | Dallas | Texas | 75246 | — |
| Local Institution - 0012 | Houston | Texas | 77030-4009 | — |
| Local Institution - 0241 | Seattle | Washington | 98101 | — |
| Local Institution - 0067 | Seattle | Washington | 98109 | — |
| Local Institution - 0069 | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 166 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02743494, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 18, 2025 · Synced Oct 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02743494 live on ClinicalTrials.gov.